Maximus (NYSE:MMS - Get Free Report) issued its quarterly earnings data on Thursday. The health services provider reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.85 by $0.26, Zacks reports. Maximus had a net margin of 7.07% and a return on equity of 24.91%. Maximus updated its FY 2027 guidance to 7.500-8.000 EPS.
Maximus Trading Up 1.3%
Shares of Maximus stock opened at $65.26 on Thursday. Maximus has a fifty-two week low of $51.04 and a fifty-two week high of $100.00. The company has a debt-to-equity ratio of 0.90, a quick ratio of 2.42 and a current ratio of 2.42. The company has a market capitalization of $3.42 billion, a P/E ratio of 9.64 and a beta of 0.57. The company has a fifty day moving average of $59.97 and a 200 day moving average of $63.12.
Maximus Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 30th. Investors of record on Friday, November 13th will be issued a $0.33 dividend. The ex-dividend date of this dividend is Friday, November 13th. This represents a $1.32 annualized dividend and a yield of 2.0%. Maximus's dividend payout ratio is currently 19.50%.
Insider Buying and Selling
In other Maximus news, insider Michelle Link sold 3,208 shares of the firm's stock in a transaction dated Thursday, October 1st. The stock was sold at an average price of $54.23, for a total transaction of $173,969.84. Following the sale, the insider directly owned 13,881 shares of the company's stock, valued at $752,766.63. This trade represents a 18.77% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 1.80% of the stock is currently owned by corporate insiders.
Analyst Upgrades and Downgrades
MMS has been the subject of several recent research reports. Weiss Ratings restated a "hold (c-)" rating on shares of Maximus in a research report on Friday, November 13th. Wall Street Zen downgraded shares of Maximus from a "buy" rating to a "hold" rating in a research report on Saturday, August 8th. Finally, Zacks Research upgraded shares of Maximus from a "strong sell" rating to a "hold" rating in a research report on Thursday, October 1st. Two equities research analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, the stock currently has an average rating of "Hold".
Get Our Latest Analysis on MMS
Maximus Company Profile
(
Get Free Report)
Maximus, Inc. provides technology-enabled services to government agencies, helping them administer public programs and deliver services to residents. Its work includes managing contact centers, processing applications and eligibility determinations, conducting health assessments, and supporting appeals and other case-management functions. The company serves clients in the United States and internationally, including government agencies in the United Kingdom, Canada and Australia. Its services span health and human services programs as well as federal government operations, with technology and digital services supporting its program work.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.